kallikrein-kinin bradykinin
Selected indexed studies
- Innate immunity in diabetic kidney disease. (Nat Rev Nephrol, 2020) [PMID:31942046]
- Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists. (ScientificWorldJournal, 2006) [PMID:17041716]
- Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors. (Pharmacology, 2000) [PMID:10754447]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Innate immunity in diabetic kidney disease. (2020) pubmed
- Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists. (2006) pubmed
- Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors. (2000) pubmed
- Kinin-kallikrein system: New perspectives in heart failure. (2024) pubmed
- Kallikrein-kinin system in hepatic experimental models. (2005) pubmed
- Plasma kallikrein: the bradykinin-producing enzyme. (2013) pubmed
- Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides. (2000) pubmed
- ACE inhibitor-induced angioedema. (2013) pubmed
- Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity. (2022) pubmed
- The kallikrein-kinin system in humans. (2001) pubmed